NCT03020537View on ClinicalTrials.gov

B-cell Immunity to Influenza (SLVP017)- Year 5, 2013

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Influenza
Interventions
BIOLOGICAL

Fluzone

Fluzone (Influenza Virus Vaccine) Suspension for Intramuscular Injection 2013-2014 Formula.

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Stanford University

OTHER

NCT03020537 - B-cell Immunity to Influenza (SLVP017)- Year 5, 2013 | Biotech Hunter | Biotech Hunter